Jul 102017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – PharmaCyte Biotech, Inc. (OTCMKTS:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced the appointment of Dr.=> Read more

PharmaCyte Biotech appoints Dr Michael Abecassis to its Board of Directors

From:: PharmaCyte Biotech appoints Dr Michael Abecassis to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: